Pediatrics Medical News about Myoclonic Epilepsies, Progressive

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Early Myoclonic Encephalopathy and Nonketotic Hyperglycinemia
Pediatric Neurology , 10/20/09

Rossi S et al. – The neonatal form is a severe, frequently lethal neurologic disease. When associated with electro–clinical features, progressive lethargy and hypotonia occur in the first days of life, progressing to apnea and often death. Prospective treatment with oral sodium benzoate, the N–methyl–d–aspartate receptor antagonist ketamine, and dextromethorphan can favorably modify the early neonatal course of severe nonketotic hyperglycinemia, but does not prevent poor long–term outcomes.

<< Previous
Medication Policy After Epilepsy Surgery

Next >>
A 10-Month-Old Infant With Reversible Findings of Brain Death

Focal clinical and electroencephalographic features in patients with juvenile myoclonic epilepsy
Acta Neurologica Scandinavica, 10/22/09 Relevance Score: 66%

Operative Treatment of Epilepsy
JAMA, 10/15/09 Relevance Score: 66%

Perfusion SPECT Findings in a Suspected Case of Rasmussen Encephalitis
Journal of Neuroimaging, 10/07/09 Relevance Score: 64%

Micrographia and hypophonia in anorexia nervosa
International Journal of Eating Disorders, 11/04/09 Relevance Score: 63%

Current and future treatment of epilepsy
The Internet Journal of Neurology, 11/03/09 Relevance Score: 46%